Overview

Study of Uptake, Break Down and Elimination of an Investigational Drug in Healthy Volunteers

Status:
Terminated
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
This study is being performed in order to learn more about a new drug (possible as treatment for people with Alzheimer's Disease and other conditions with cognitive dysfunction (memory and attention problems)) and how it is handled by the body by giving the drug to healthy volunteers with different genotypes.
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca